ARCHIVES

AZURE Trial: Zoledronic Acid Didn’t Improve DFS In Stage II/III

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

Program Project Payline Is 125; Budget Cuts Will Allow NCI To Fund 49 Competing P01s

February 28, 1992

NCA To Hear Centers’ Reaction, Other Subcommittee, Scientific Reports

November 11, 1977

NIH Investigation Clear Gallo Of Charge He Stole Aids Virus

October 12, 1990

In Brief: FDA Oncological Drugs Advisory Committee Gets New Charter, Georgetown’s Schein Is Chairman

October 13, 1978

Report Says Many Cancers Could Be Prevented

February 27, 2009

Bloch Dissatisfied With PDQ, Offers $1 Million To fund “Tailored” Treatment Data To Physicians

November 13, 1987